EPIDIOLEX

This brand name is authorized in Israel, United States

Active ingredients

The drug EPIDIOLEX contains one active pharmaceutical ingredient (API):

1 Cannabidiol UNII 19GBJ60SN5 - CANNABIDIOL

Cannabidiol is indicated for the treatment of seizures associated with Lennox‑Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in patients 1 year of age and older. Read about Cannabidiol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EPIDIOLEX Oral solution	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N03AX24		N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AX Other antiepileptics
Discover more medicines within N03AX24

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8767
Country: US	FDA, National Drug Code	Identifier(s): 70127-100